The study conducted by Loma Linda University aims to establish normative values for cerebral blood flow (CBF) across various brain regions using a novel MRI technique. This non-invasive method has potential applications in diagnosing and managing brain disorders such as traumatic brain injury, multiple sclerosis, and Alzheimer's disease. The successful establishment of normative CBF values could enhance the reliability of pCASL MRI in clinical settings, positioning it as a competitive alternative to existing imaging modalities. The market for advanced neuroimaging techniques is growing, driven by increasing incidences of neurological disorders and the demand for non-invasive diagnostic tools. Companies developing or utilizing similar imaging technologies may face competitive pressures, and the findings from this study could influence their product development strategies.